Zoetis | ZTS - Gross Profit On Sales

Stock Price
77.72
Daily Change
3.50 4.72%
Monthly
-36.67%
Yearly
-52.59%
Q2 Forecast
72.73

Zoetis reported $1.62B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
AbbVie USD 12.54B 474M Mar/2026
Align Technology USD 736.59M 53M Mar/2026
Bayer EUR 6.94B 1.58B Dec/2025
Bristol-Myers Squibb USD 8.41B 381M Dec/2025
Charles River Laboratories USD 279.32M 7.36M Mar/2026
Coherus Biosciences USD 8.7M 853K Dec/2025
Dentsply International USD 427M 16M Mar/2026
Eli Lilly USD 15.92B 1.33B Dec/2025
Henry Schein USD 1.07B 7M Mar/2026
Idexx Laboratories USD 722.74M 64.62M Mar/2026
Illumina USD 721M 38M Mar/2026
IQVIA Holdings USD 1.07B 52M Mar/2026
J&J USD 17.24B 642M Mar/2026
Laboratory Of America USD 1.01B 20.6M Mar/2026
Merck USD 10.85B 2.57B Dec/2025
Neogen USD 99M 7.7M Dec/2025
Pacira USD 126.64M 15.61M Mar/2026
Perrigo USD 325.5M 36.7M Mar/2026
Pfizer USD 11.04B 1.24B Mar/2026
Phibro Animal Health USD 133.5M 12.6M Dec/2025
Quest Diagnostics USD 906M 33M Mar/2026
Sanofi EUR 8.45B 1.31B Dec/2025
Sanofi EUR 8.45B 3.02B Dec/2025
Zoetis USD 1.62B 20M Mar/2026